# A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose

> **NCT07406334** · PHASE1 · NOT_YET_RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 45 (estimated)

## Conditions studied

- Pneumonia, Bacterial

## Interventions

- **BIOLOGICAL:** Pn-MAPS30plus
- **COMBINATION_PRODUCT:** PCV20

## Key facts

- **NCT ID:** NCT07406334
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2027-02-22
- **Final completion:** 2027-02-22
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07406334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07406334, "A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07406334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*